Seidel D, Simon M, Sprute R, et al. - Researchers sought to describe the disease burden as well as the clinical presentation of COVID-19–associated mucormycosis (CAM) in Germany.

• Through German mycology networks and scientific societies, 13 CAM cases diagnosed between March 2020 and June 2021 were retrieved.

• There was a rare occurrence of CAM in Germany.

• Mostly it developed in cases with comorbidities and impaired immune system and severe COVID-19 treated in the ICU with high mortality compared with mainly rhino-orbito-cerebral CAM in patients with mild COVID-19 in India.

• Hospitalized COVID-19 patients appeared to be at higher risk for CAM than other patients.